Sera Prognostics is developing a biomarker test for predicting very preterm birth.
- Don’t Miss These Solutions from Virtual Engineering Week Exhibitors
- Well Health Brings Home $45M in Series C Round
- GT Medical Brings in $16M to Change Tumor Treatment Paradigm
- Let’s Talk Medtech: Here’s a Tool Every Medical Device Rep Needs
- GE Healthcare Acquires Prismatic Sensors for Undisclosed Sum
- Siemens Solidifies Position in COVID-19 Testing with New Assay